Sheldon Litwin to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Sheldon Litwin has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.100
-
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am. 1996 Mar-Apr; 2(2):99-105.
Score: 0.027
-
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol. 1995 Aug; 13(8):1860-70.
Score: 0.026
-
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Semin Oncol. 1995 Aug; 22(4 Suppl 9):18-29.
Score: 0.026
-
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):469-78.
Score: 0.022